Vascular Pharmaceuticals
Chapel Hill, US · Delaware corporation · 1 known investors
Vascular Pharmaceuticals develops VPI-2960B, a therapeutic candidate in clinical development for diabetic nephropathy treatment. The company focuses on advancing this potential breakthrough therapy through Phase 2 trials.
Founders & leadership
LM
Laura MaileCo-Founder, Director, Research and Development
RS
Richard SheaExecutive
BL
Bonnie LaymanExecutive
DC
David ClemmonsCo-Founder, Chief Scientific Officer
Board
ES
Elizabeth StonerBoard director
RK
Richard KentBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$18.1M disclosed across 2 rounds · 2012–2015
▶$3MraisedJan 2016 · 6 investors · BiotechnologyRule 506(b)
▶$3MraisedJan 2016 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Benjamin RovinskiDirector
- Elizabeth StonerDirector
- David ClemmonsDirector
- Richard SheaExecutive Officer, Director
- Bonnie LaymanExecutive Officer
- Richard KentDirector
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.1MraisedFeb 2015 · 6 investors · BiotechnologyRule 506(b)
▶$15.1MraisedFeb 2015 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David ClemmonsDirector
- Richard SheaExecutive Officer, Director
- Richard KentDirector
- Elizabeth StonerDirector
- Bonnie LaymanExecutive Officer
- Offering amount
- $25.1M
- Amount sold
- $15.1M
- First sale
- Sep 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Medscape15 shared keywordsMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
UPMC9 shared keywordsUPMC is a regional healthcare provider that invests in community health through charity care, free and subsidized health programs, and support for seniors, veterans, and food-insecure populations.
Companies competing with Vascular Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Vascular Pharmaceuticals do?
- Vascular Pharmaceuticals develops VPI-2960B, a therapeutic candidate in clinical development for diabetic nephropathy treatment. The company focuses on advancing this potential breakthrough therapy through Phase 2 trials.
- Who founded Vascular Pharmaceuticals?
- Vascular Pharmaceuticals was founded by Laura Maile.
- Who are Vascular Pharmaceuticals's investors?
- Vascular Pharmaceuticals's investors include MPM BioImpact.
- How much funding has Vascular Pharmaceuticals raised?
- Vascular Pharmaceuticals has disclosed $18.1M raised across 2 rounds.
- Where is Vascular Pharmaceuticals headquartered?
- Vascular Pharmaceuticals is headquartered in Chapel Hill, US.